Molecular sampling of prostate cancer: a dilemma for predicting disease progression

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

Show other versions (1)

Background: Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence, we sought to develop a molecular panel for prostate can...

Full description

Bibliographic Details
Main Authors: Sboner, Andrea (Author), Demichelis, Francesca (Author), Calza, Stefano (Author), Pawitan, Yudi (Author), Setlur, Sunita R. (Author), Hoshida, Yujin (Contributor), Perner, Sven (Author), Adami, Hans-Olov (Author), Fall, Katja (Author), Mucci, Lorelei A. (Author), Kantoff, Philip W. (Author), Stampfer, Meir (Author), Andersson, Swen-Olof (Author), Varenhorst, Eberhard (Author), Johansson, Jan-Erik (Author), Gerbstein, Mark B. (Author), Golub, Todd R. (Author), Rubin, Mark A. (Author), Andren, Ove (Author)
Other Authors: Harvard University- (Contributor)
Format: Article
Language:English
Published: BioMed Central Ltd., 2012-03-01T17:03:50Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items